Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tara McCready

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
BMJ (Clinical Research Ed.)|June 12, 2020
Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): pragmatic randomised controlled trialNoah M Ivers, Jon-David Schwalm, Zachary Bouck, et al.
Globalization and Health|March 17, 2017
Developing consensus measures for global programs: lessons from the Global Alliance for Chronic Diseases Hypertension research programMichaela A Riddell, Nancy Edwards, Simon R Thompson, et al.
European Heart Journal|August 28, 2023
Frailty and outcomes in heart failure patients from high-, middle-, and low-income countriesDarryl P Leong, Philip Joseph, John J V McMurray, et al.
European Journal of Heart Failure|December 15, 2024
The risk of death according to left ventricular ejection fraction and right ventricular dilatation in 17 321 adults with heart failure from 40 high-, middle- and low-income countries - A Global Congestive Heart Failure (G-CHF) studyDarryl P Leong, Philip G Joseph, Hisham Dokainish, et al.
The New England Journal of Medicine|November 13, 2020
Polypill with or without Aspirin in Persons without Cardiovascular DiseaseSalim Yusuf, Philip Joseph, Antonio Dans, et al.
American Heart Journal|August 2, 2017
Interventions Supporting Long-term Adherence aNd Decreasing cardiovascular events (ISLAND): Pragmatic randomized trial protocolNoah Ivers, J-D Schwalm, Holly O Witteman, et al.
European Journal of Heart Failure|May 15, 2022
Factors associated with health-related quality of life in heart failure in 23 000 patients from 40 countries: results of the G-CHF research programmeIsabelle Johansson, Kumar Balasubramanian, Shrikant Bangdiwala, et al.
CJC Open|September 2, 2025
Efficacy and Safety of Transcatheter Mitral Valve Edge-to-Edge Repair with a MitraClip Device in Real-World Canadian PracticeShamir R Mehta, Anita Asgar, Robert Boone, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 9, 2022
Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trialShamir R Mehta, Guillaume Pare, Eva M Lonn, et al.
The Lancet. Global Health|November 18, 2022
Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trialMark Loeb, Ambuj Roy, Hisham Dokainish, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
BMJ (Clinical Research Ed.)|June 12, 2020
Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): pragmatic randomised controlled trialNoah M Ivers, Jon-David Schwalm, Zachary Bouck, et al.
Globalization and Health|March 17, 2017
Developing consensus measures for global programs: lessons from the Global Alliance for Chronic Diseases Hypertension research programMichaela A Riddell, Nancy Edwards, Simon R Thompson, et al.
European Heart Journal|August 28, 2023
Frailty and outcomes in heart failure patients from high-, middle-, and low-income countriesDarryl P Leong, Philip Joseph, John J V McMurray, et al.
European Journal of Heart Failure|December 15, 2024
The risk of death according to left ventricular ejection fraction and right ventricular dilatation in 17 321 adults with heart failure from 40 high-, middle- and low-income countries - A Global Congestive Heart Failure (G-CHF) studyDarryl P Leong, Philip G Joseph, Hisham Dokainish, et al.
The New England Journal of Medicine|November 13, 2020
Polypill with or without Aspirin in Persons without Cardiovascular DiseaseSalim Yusuf, Philip Joseph, Antonio Dans, et al.
American Heart Journal|August 2, 2017
Interventions Supporting Long-term Adherence aNd Decreasing cardiovascular events (ISLAND): Pragmatic randomized trial protocolNoah Ivers, J-D Schwalm, Holly O Witteman, et al.
European Journal of Heart Failure|May 15, 2022
Factors associated with health-related quality of life in heart failure in 23 000 patients from 40 countries: results of the G-CHF research programmeIsabelle Johansson, Kumar Balasubramanian, Shrikant Bangdiwala, et al.
CJC Open|September 2, 2025
Efficacy and Safety of Transcatheter Mitral Valve Edge-to-Edge Repair with a MitraClip Device in Real-World Canadian PracticeShamir R Mehta, Anita Asgar, Robert Boone, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 9, 2022
Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trialShamir R Mehta, Guillaume Pare, Eva M Lonn, et al.
The Lancet. Global Health|November 18, 2022
Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trialMark Loeb, Ambuj Roy, Hisham Dokainish, et al.
Pageof 4